Suppliers and packagers for ROGAINE (FOR WOMEN)

ROGAINE (FOR WOMEN)

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Kenvue Brands	ROGAINE (FOR WOMEN)	minoxidil	SOLUTION;TOPICAL	019501	NDA	Kenvue Brands LLC	69968-0090-1	1 BOTTLE, PLASTIC in 1 CARTON (69968-0090-1) / 60 mL in 1 BOTTLE, PLASTIC	2010-08-01
Kenvue Brands	ROGAINE (FOR WOMEN)	minoxidil	SOLUTION;TOPICAL	019501	NDA	Kenvue Brands LLC	69968-0090-3	3 BOTTLE, PLASTIC in 1 CARTON (69968-0090-3) / 60 mL in 1 BOTTLE, PLASTIC	2010-08-01

Suppliers for Rogaine (For Women): Key Manufacturing, Ingredient Sourcing, and Contract Supply Risk Map

Last updated: June 15, 2026

Rogaine (for women) is an OTC topical minoxidil product. The supplier universe breaks into (1) active pharmaceutical ingredient (API) and key raw materials, (2) contract manufacturing organizations (CMOs) and packaging sites, and (3) regulatory-affecting quality systems. This report identifies the known supplier and manufacturing reference points that matter for supply continuity and IP defensibility, then maps the practical acquisition and replacement options used in this product class.

Which companies supply Rogaine for women (topical minoxidil) and who manufactures the finished product?

Rogaine for women is sold by Johnson & Johnson Consumer Inc. (J&J) and marketed as an OTC topical minoxidil formulation. The finished-dose “supplier” chain typically comprises an API/minoxidil raw material supplier, excipient suppliers, and a CMO that performs compounding, filling, and packaging to J&J specifications.

Finished product and market owner

• Brand/Marketing authorization holder: Johnson & Johnson Consumer Inc. (J&J) (OTC minoxidil topical brand “Rogaine”)

Direct supplier naming

• Public sources for Rogaine often identify the manufacturer on the package/label (site-specific) rather than listing the API and excipient suppliers in procurement terms.
• For topical OTC minoxidil solutions and foams, the supply pattern in the US market is typically handled through J&J’s long-term CMO relationships and multiple approved manufacturing sites, with ingredient qualification through J&J’s quality system.

Because you asked for “suppliers,” the actionable way to identify the actual supply chain is to anchor on (a) labeled manufacturing sites for the specific dosage form and (b) minoxidil API supply used in that formulation. That linkage is what determines the realistic alternates for scale-up, substitution, and continuity.

What suppliers provide the minoxidil API used for Rogaine formulations?

Minoxidil is a widely manufactured small-molecule API. The practical supplier list for a topical minoxidil product normally includes multiple API sources qualified by the brand owner, because minoxidil supply is subject to raw material availability and manufacturing capacity.

Common API supply realities for minoxidil topical products

• Minoxidil API suppliers typically compete on DMF/DMF-equivalent dossier support (where used), impurity profile control, and ongoing batch release stability.
• API is almost always purchased as an intermediate-to-finished input with tight specifications tied to topical product performance (solubility, dissolution/availability, and stability).

What you can verify from procurement and compliance workflow

• The API supplier is generally reflected in either:
  • supplier qualifications maintained by the brand owner and its quality group, or
  • the site listed on the manufacturing record/COA traceability, which usually matches the labeled manufacturer/packager for that lot.

Key implication for “supplier” decisions

• The supplier set for Rogaine is not a single-name procurement list. It is a qualified multi-supplier API panel governed by stability, impurities, and formulation performance across lots.

Which contract manufacturers (CMOs) produce Rogaine topical minoxidil for women?

For topical OTC products, CMOs usually handle:

• compounding to formulation specs
• bulk solution preparation or foam preparation (for foam formats)
• filling into bottles, droppers, and dispensers
• overwrap, carton pack, and labeling

How to identify the actual CMO

• The highest signal is the manufacturer/packer listed on the product label for the exact dosage form and strength (solution vs foam).
• OTC labeling and distribution frequently includes different sites per lot for continuity planning, which affects supplier reliability and change-control.

Actionable supplier mapping

• In practice, procurement and litigation teams use these steps:
  1. Collect package labels across lots
  2. Record the labeled manufacturing/packaging site name and address
  3. Map that site to known CMO capabilities (topical liquids vs propellant foams)
  4. Link stability and complaint history to the manufacturing site

This is the only method that yields a reliable “who supplies” answer at the finished-product level.

What raw material suppliers matter most for Rogaine (excipient and container system sourcing)?

Topical minoxidil formulations depend on the excipient package that controls:

• solubilization (especially for minoxidil in topical systems)
• viscosity and spreading
• preservative/antimicrobial performance
• foam or solution rheology and dispenser performance (for foam formats)

Raw materials that typically drive supplier risk in minoxidil topicals

• Solvents/co-solvents used for minoxidil solubilization (supplier qualification affects odor, evaporation, and stability)
• Alcohol content and denaturation grade (if applicable in that formulation)
• Propellant and valve/dispenser components (for foam formats)
• Packaging integrity components:
  • bottles and closures
  • dropper systems
  • foam canisters and valves (if foam)
  • liners, gaskets, and coatings compatibility with minoxidil and ethanol

Container-closure supplier is a compliance and performance variable

• Even when the active and excipients remain constant, changing packaging can alter:
  • extractables and leachables
  • dispensing dose uniformity
  • shelf life

Supplier selection in topical OTC products is therefore as much about container systems as it is about API and bulk excipients.

How can you confirm the Rogaine supplier for a specific lot (label manufacturer vs actual API source)?

The “supplier” that matters operationally is not only the API manufacturer. For continuity, the practical hierarchy is:

1. Labeled manufacturer/packer for the finished product (governs release and supply continuity)
2. Qualified API supplier used for that lot (governs long-term availability, impurity risk, and change-control)
3. Key component suppliers (packaging valves/closures, dispensers) that can drive discontinuity

Lot traceability approach

• For each lot sold, extract:
  • manufacturer site printed on the bottle/carton label
  • lot number
• Then request:
  • supplier traceability records for API and critical components from the brand owner or CMO via quality agreements

This provides the definitive supplier map used in procurement replacement scenarios.

When do supplier changes for Rogaine trigger regulatory or quality actions (OTC minoxidil)?

Supplier changes for OTC actives and excipients can trigger:

• comparability/stability re-evaluation
• updated quality agreements
• sometimes regulatory notification paths depending on the change category

Quality-triggering changes

• API source change with altered impurity profile
• change in container-closure system that affects extractables/leachables
• change in dispenser or valve system (foam formats)

Operational consequence

• Supplier substitution for topical minoxidil typically requires at least:
  • qualification batches
  • stability data under labeled conditions
  • label/pack engineering verification (dose delivery and leakage)

What is the practical supplier substitution path if a Rogaine minoxidil supplier becomes constrained?

Topical OTC supply continuity usually uses a multi-lane strategy:

• parallel CMO manufacturing sites (if the product is already manufactured in multiple sites)
• multiple qualified API sources
• qualified packaging component alternates for valves/closures/dispenser components

Procurement posture used in the category

• lock in contract options for critical components
• pre-qualify alternates through engineering batches
• keep change-control templates ready for quick executed comparability studies

Key takeaways

• “Suppliers for Rogaine (for women)” are best defined as (1) labeled finished-product manufacturer/packer sites, (2) qualified minoxidil API suppliers, and (3) critical excipient and container-closure/dispensing component suppliers.
• Finished-product suppliers change by lot and dosage form, so the most reliable identification method is the manufacturer/packer printed on the specific Rogaine label for the targeted strength and form.
• For topical minoxidil, supplier risk often concentrates in API impurity control and container/dispensing systems, especially if the formulation uses foam canisters and valves.

FAQs

1) Who is the manufacturer on Rogaine (for women) labels?

The label lists the manufacturer/packer site for the specific product strength and dosage form. That site is the most actionable “supplier” for finished goods continuity.

2) Is minoxidil the only active ingredient in Rogaine for women?

Yes, Rogaine is a minoxidil topical product; the rest of the formulation is excipients and delivery/packaging components.

3) Do different Rogaine formats (solution vs foam) use different supply chains?

Yes. Foam formats typically add packaging and dispensing components such as canisters and valves, which changes the critical supplier set.

4) Can Rogaine use multiple qualified minoxidil API suppliers?

Yes. Brands in this category typically qualify multiple API sources to mitigate supply disruptions, subject to impurity and performance equivalence.

5) What supplier changes are most likely to cause product quality issues?

API source changes with impurity profile drift and packaging/dispensing system changes that affect extractables, dose delivery, or shelf life.

References

1. DailyMed. “ROGAINE (minoxidil) topical.” U.S. National Library of Medicine.
2. FDA. “OTC Drug Manufacturing Compliance Program” and related OTC quality guidance materials. U.S. Food and Drug Administration.
3. Orange Book (Drugs@FDA). “Minoxidil” and referenced products listings (where applicable). U.S. FDA.